AI assistant
Catheter Precision, Inc. — Proxy Solicitation & Information Statement 2020
Oct 16, 2020
35479_rns_2020-10-16_4d7c0862-766b-468d-95ed-f149c9c597da.zip
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
DEFA14A 1 rmed-defa14a_20201015.htm DEFA14A HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" rmed-defa14a_20201015.htm NG Converter v5.0.2.50
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a‑12 |
Ra Medical Systems, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ No fee required.
☐ Fee computed on table below per Exchange Act Rules 14a‑6(i)(1) and 0‑11.
| (1) | Title of each class of securities to which transaction applies: |
|---|---|
| (2) | Aggregate number of securities to which transaction applies: |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0‑11 (Set forth the amount on which the filing fee is calculated and state how it was determined): |
| (4) | Proposed maximum aggregate value of transaction: |
| (5) | Total fee paid: |
☐ Fee paid previously with preliminary materials.
☐ Check box if any part of the fee is offset as provided by Exchange Act Rule 0‑11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
| (1) | Amount Previously Paid: |
|---|---|
| (2) | Form, Schedule or Registration Statement No.: |
| (3) | Filing Party: |
(4) Date Filed:
On September 2 , 2020, Ra Medical Systems, Inc. (the “Company”) commenced distributing to its stockholders a Notice of Annual Meeting of Stockholders and Definitive Proxy Statement (the “Notice and Proxy Statement”) for its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) to be held on October 12, 2020. A copy of the Notice and Proxy Statement was filed with the Securities and Exchange Commission on August 28, 2020. On October 12 , 2020 the Annual Meeting was adjourned prior to voting on Proposal 3 to allow additional time for voting. As announced during the Annual Meeting, the Annual Meeting is to reconvene at 9:00 a .m. Pacific Time on November 2 , 2020. On October 15 , 2020, the Company (i) mailed a letter to certain of its stockholders (the “Letter”), and (ii) commenced disseminating an audio recording (the “Recording”) to certain of its stockholders by telephone, in each case related to Proposal 3 , which pr oposal is described in the Notice and Proxy Statement . A copy of the Letter and a script of the Recording is set forth below.
200 Broadacres Drive, 3rd Floor Bloomfield, NJ 07003 P: 973.873.7700 F: 973.338.1430 www.allianceadvisors.com
Date: October 15, 2020
WE STILL NEED YOUR VOTE
PLEASE VOTE YOUR SHARES TODAY
Dear Fellow Stockholders:
The Annual Meeting of Stockholders has been adjourned until November 2, 2020. According to our latest records, your vote has not yet been received.
We strongly encourage you to vote your shares today. Please call one of our proxy specialists toll-free at (833) 945 – 2699 between the hours of 9:00 a.m. and 10:00 p.m., Eastern Time, Monday through Friday.
Alternatively, you can email me your voting instructions at [email protected] .
Sincerely,
Melissa Carlson
Vice President
VOTE TODAY
CALL TOLL – FREE
(833) 945 - 2699
The Shareholder Communication Strategists
Copyright © 2020 by Alliance Advisors, LLC. ALL RIGHTS RESERVED
Recording Script
Hi, this is Will McGuire, CEO of Ra Medical Systems, Inc. We are asking you to approve a reverse stock split, a proposal that was scheduled to be voted on at the Annual Meeting of Stockholders on October 12, 2020 but has been adjourned until November 2, 2020.
The reverse stock split is necessary in order to maintain our continued listing on the New York Stock Exchange.
You can vote now by pressing 1 and be connected to a live agent who can take your vote on a recorded line. If you are listening to this message on your voicemail, feel free to call 833-945-2699 Monday through Friday between the hours of 9:00am and 10:00pm Eastern time to vote your shares.